Application of radiofrequency ablation for the treatment of metastatic liver cancers

Kazuhiro Nouso, Yoshiyuki Kobayashi, Shinichiro Nakamura, Shuji Uematsu, Kunihiro Shiraga, Shouta Iwadou, Yasuyuki Araki, Hideaki Taniguchi, Hironori Tanaka, Nobuyuki Toshikuni, Toshihiko Kaneyoshi, Hiroshi Ikeda, Shinichi Fujioka, Toshiya Osawa, Yoshiaki Iwasaki, Hidenori Shiraha, Kazuhide Yamamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background/Aims: The aim of this study is to elucidate the effectiveness of radiofrequency ablation (RFA) for the treatment of metastatic liver cancers. Methodology: From 74 patients with metastatic liver cancers treated by RFA, 40 patients including 23 colon cancer who had received curative resection of the primary tumor were analyzed. Results: Recurrence of the tumor was observed in 29 (72.5%) patients. The most prevalent site of recurrence was the liver in both colon cancer (10/15, 66.7%) and non-colon cancer patients (12/14, 85.7%). Among the recurrence in the liver, the rate of intrahepatic distant recurrence (recurrence outside of the RFA-treated segment) was high in both colon cancer (55.6%) and non-colon cancer patients (69.0%). Local recurrence (recurrence at the RFA-treated segment) rate was low (32.6% and 32.9%, respectively) and none of single tumor less than 2cm in diameter showed local recurrence. The intrahepatic recurrence was single in 67.6% of the patients and 59.1% of the patients were re-treated by RFA. Conclusions: RFA is a less-invasive method for the treatment of metastatic liver tumors and can be performed repetitively. Although the rate of intra-hepatic distant recurrence and extra-hepatic recurrence was high, good local control can be achieved by RFA.

Original languageEnglish
Pages (from-to)117-120
Number of pages4
JournalHepato-Gastroenterology
Volume57
Issue number97
Publication statusPublished - Jan 2010

Fingerprint

Liver Neoplasms
Recurrence
Therapeutics
Liver
Colonic Neoplasms
Neoplasms

Keywords

  • Liver neoplasm
  • Metastasis
  • Prognosis
  • Therapeutics

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Nouso, K., Kobayashi, Y., Nakamura, S., Uematsu, S., Shiraga, K., Iwadou, S., ... Yamamoto, K. (2010). Application of radiofrequency ablation for the treatment of metastatic liver cancers. Hepato-Gastroenterology, 57(97), 117-120.

Application of radiofrequency ablation for the treatment of metastatic liver cancers. / Nouso, Kazuhiro; Kobayashi, Yoshiyuki; Nakamura, Shinichiro; Uematsu, Shuji; Shiraga, Kunihiro; Iwadou, Shouta; Araki, Yasuyuki; Taniguchi, Hideaki; Tanaka, Hironori; Toshikuni, Nobuyuki; Kaneyoshi, Toshihiko; Ikeda, Hiroshi; Fujioka, Shinichi; Osawa, Toshiya; Iwasaki, Yoshiaki; Shiraha, Hidenori; Yamamoto, Kazuhide.

In: Hepato-Gastroenterology, Vol. 57, No. 97, 01.2010, p. 117-120.

Research output: Contribution to journalArticle

Nouso, K, Kobayashi, Y, Nakamura, S, Uematsu, S, Shiraga, K, Iwadou, S, Araki, Y, Taniguchi, H, Tanaka, H, Toshikuni, N, Kaneyoshi, T, Ikeda, H, Fujioka, S, Osawa, T, Iwasaki, Y, Shiraha, H & Yamamoto, K 2010, 'Application of radiofrequency ablation for the treatment of metastatic liver cancers', Hepato-Gastroenterology, vol. 57, no. 97, pp. 117-120.
Nouso K, Kobayashi Y, Nakamura S, Uematsu S, Shiraga K, Iwadou S et al. Application of radiofrequency ablation for the treatment of metastatic liver cancers. Hepato-Gastroenterology. 2010 Jan;57(97):117-120.
Nouso, Kazuhiro ; Kobayashi, Yoshiyuki ; Nakamura, Shinichiro ; Uematsu, Shuji ; Shiraga, Kunihiro ; Iwadou, Shouta ; Araki, Yasuyuki ; Taniguchi, Hideaki ; Tanaka, Hironori ; Toshikuni, Nobuyuki ; Kaneyoshi, Toshihiko ; Ikeda, Hiroshi ; Fujioka, Shinichi ; Osawa, Toshiya ; Iwasaki, Yoshiaki ; Shiraha, Hidenori ; Yamamoto, Kazuhide. / Application of radiofrequency ablation for the treatment of metastatic liver cancers. In: Hepato-Gastroenterology. 2010 ; Vol. 57, No. 97. pp. 117-120.
@article{5c5cef68bce04d77b9908c6c5a8d9ef6,
title = "Application of radiofrequency ablation for the treatment of metastatic liver cancers",
abstract = "Background/Aims: The aim of this study is to elucidate the effectiveness of radiofrequency ablation (RFA) for the treatment of metastatic liver cancers. Methodology: From 74 patients with metastatic liver cancers treated by RFA, 40 patients including 23 colon cancer who had received curative resection of the primary tumor were analyzed. Results: Recurrence of the tumor was observed in 29 (72.5{\%}) patients. The most prevalent site of recurrence was the liver in both colon cancer (10/15, 66.7{\%}) and non-colon cancer patients (12/14, 85.7{\%}). Among the recurrence in the liver, the rate of intrahepatic distant recurrence (recurrence outside of the RFA-treated segment) was high in both colon cancer (55.6{\%}) and non-colon cancer patients (69.0{\%}). Local recurrence (recurrence at the RFA-treated segment) rate was low (32.6{\%} and 32.9{\%}, respectively) and none of single tumor less than 2cm in diameter showed local recurrence. The intrahepatic recurrence was single in 67.6{\%} of the patients and 59.1{\%} of the patients were re-treated by RFA. Conclusions: RFA is a less-invasive method for the treatment of metastatic liver tumors and can be performed repetitively. Although the rate of intra-hepatic distant recurrence and extra-hepatic recurrence was high, good local control can be achieved by RFA.",
keywords = "Liver neoplasm, Metastasis, Prognosis, Therapeutics",
author = "Kazuhiro Nouso and Yoshiyuki Kobayashi and Shinichiro Nakamura and Shuji Uematsu and Kunihiro Shiraga and Shouta Iwadou and Yasuyuki Araki and Hideaki Taniguchi and Hironori Tanaka and Nobuyuki Toshikuni and Toshihiko Kaneyoshi and Hiroshi Ikeda and Shinichi Fujioka and Toshiya Osawa and Yoshiaki Iwasaki and Hidenori Shiraha and Kazuhide Yamamoto",
year = "2010",
month = "1",
language = "English",
volume = "57",
pages = "117--120",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "97",

}

TY - JOUR

T1 - Application of radiofrequency ablation for the treatment of metastatic liver cancers

AU - Nouso, Kazuhiro

AU - Kobayashi, Yoshiyuki

AU - Nakamura, Shinichiro

AU - Uematsu, Shuji

AU - Shiraga, Kunihiro

AU - Iwadou, Shouta

AU - Araki, Yasuyuki

AU - Taniguchi, Hideaki

AU - Tanaka, Hironori

AU - Toshikuni, Nobuyuki

AU - Kaneyoshi, Toshihiko

AU - Ikeda, Hiroshi

AU - Fujioka, Shinichi

AU - Osawa, Toshiya

AU - Iwasaki, Yoshiaki

AU - Shiraha, Hidenori

AU - Yamamoto, Kazuhide

PY - 2010/1

Y1 - 2010/1

N2 - Background/Aims: The aim of this study is to elucidate the effectiveness of radiofrequency ablation (RFA) for the treatment of metastatic liver cancers. Methodology: From 74 patients with metastatic liver cancers treated by RFA, 40 patients including 23 colon cancer who had received curative resection of the primary tumor were analyzed. Results: Recurrence of the tumor was observed in 29 (72.5%) patients. The most prevalent site of recurrence was the liver in both colon cancer (10/15, 66.7%) and non-colon cancer patients (12/14, 85.7%). Among the recurrence in the liver, the rate of intrahepatic distant recurrence (recurrence outside of the RFA-treated segment) was high in both colon cancer (55.6%) and non-colon cancer patients (69.0%). Local recurrence (recurrence at the RFA-treated segment) rate was low (32.6% and 32.9%, respectively) and none of single tumor less than 2cm in diameter showed local recurrence. The intrahepatic recurrence was single in 67.6% of the patients and 59.1% of the patients were re-treated by RFA. Conclusions: RFA is a less-invasive method for the treatment of metastatic liver tumors and can be performed repetitively. Although the rate of intra-hepatic distant recurrence and extra-hepatic recurrence was high, good local control can be achieved by RFA.

AB - Background/Aims: The aim of this study is to elucidate the effectiveness of radiofrequency ablation (RFA) for the treatment of metastatic liver cancers. Methodology: From 74 patients with metastatic liver cancers treated by RFA, 40 patients including 23 colon cancer who had received curative resection of the primary tumor were analyzed. Results: Recurrence of the tumor was observed in 29 (72.5%) patients. The most prevalent site of recurrence was the liver in both colon cancer (10/15, 66.7%) and non-colon cancer patients (12/14, 85.7%). Among the recurrence in the liver, the rate of intrahepatic distant recurrence (recurrence outside of the RFA-treated segment) was high in both colon cancer (55.6%) and non-colon cancer patients (69.0%). Local recurrence (recurrence at the RFA-treated segment) rate was low (32.6% and 32.9%, respectively) and none of single tumor less than 2cm in diameter showed local recurrence. The intrahepatic recurrence was single in 67.6% of the patients and 59.1% of the patients were re-treated by RFA. Conclusions: RFA is a less-invasive method for the treatment of metastatic liver tumors and can be performed repetitively. Although the rate of intra-hepatic distant recurrence and extra-hepatic recurrence was high, good local control can be achieved by RFA.

KW - Liver neoplasm

KW - Metastasis

KW - Prognosis

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=77952004723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952004723&partnerID=8YFLogxK

M3 - Article

C2 - 20422885

AN - SCOPUS:77952004723

VL - 57

SP - 117

EP - 120

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 97

ER -